US Stock MarketDetailed Quotes

LUCD Lucid Diagnostics

Watchlist
  • 1.000
  • -0.050-4.76%
Close Nov 12 16:00 ET
  • 1.020
  • +0.020+2.00%
Post 16:04 ET
53.99MMarket Cap-826P/E (TTM)

About Lucid Diagnostics Company

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.

Company Profile

SymbolLUCD
Company NameLucid Diagnostics
Listing DateOct 14, 2021
Issue Price14.00
Founded2018
CEODr. Lishan Aklog, M.D.
MarketNASDAQ
Employees70
Fiscal Year Ends12-31
Address360 Madison Avenue,25th Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10017
Phone1-212-949-4319
Websitehttp://www.luciddx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lishan Aklog, M.D.
  • Chief Executive Officer and Chairman of the Board
  • 300.00K
  • Dennis M. McGrath, C.P.A.
  • Principal Accounting Officer and Chief Financial Officer
  • 225.00K
  • Shaun M. O'Neil
  • President and Chief Operating Officer
  • 162.50K
  • Stanley N. Lapidus
  • Vice Chairman of the Board
  • 214.75K
  • Dennis Matheis
  • Director
  • --
  • Dr. Jacque J. Sokolov,M.D.
  • Independent Director
  • 252.25K
  • Ronald M. Sparks, Jr
  • Independent Director
  • 262.25K
  • Debra J. White
  • Independent Director
  • 232.25K
  • Dr. James L. Cox, M.D.
  • Independent Director
  • 227.75K
  • Michael Adam Gordon
  • General Counsel and Secretary
  • 250.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data